
SynBioBeta 2026 Speaker
Shai Melcer
Israel Innovation Authority
Head of Nat'l. Bioconvergence Prog.
Dr. Shai Melcer was appointed Director of the National Bioconvergence Program, responsible for implementing the program within the TELEM Forum. Dr. Melcer holds LL.B and LL.M degrees, a PhD in Genetics from the Hebrew University, and 15 years of experience in biomedical entrepreneurship.He has collaborated with institutions including the Hebrew University, Hadassah Medical Center, IBM, and Bio-Jerusalem, and co-founded innovative biomedical ventures such as BioGiv, BIOHOUSE, and the Hadassah Accelerator. In both public and private sectors, he has worked with hundreds of bio-medical companies globally in pharma-biotech, medical devices, and digital health, many within bioconvergence. He also served as CBO at Minovia Therapeutics, a bioconvergence startup developing mitochontrial therapies.



Reagan
Jarvis
Anocca AB
CEO, Co-founder

Alex
Rives
CZI Biohub
Head of Science

Karenโฏ
Akinsanya
Schrodinger
President, R&D โ Therapeutics

Christopher
Arendt
Takeda
CSO, Head of Research

Stef
van Grieken
Cradle
CEO

Michael
Koeris
DARPA
Director, BTO

Jennifer
Dionne
Pumpkinseed
CEO

Daniyal
Hussain
GSK
Exec. Dir., Tech BD

Cynthia
Hong
Novartis
Dir., Search & Evaluation
SynBioBeta 2027 May 3-6, San Jose, California


